awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37027402-141A2DF8-F7BE-444C-B443-F1F92CDBB663
Q37027402-141A2DF8-F7BE-444C-B443-F1F92CDBB663
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37027402-141A2DF8-F7BE-444C-B443-F1F92CDBB663
Strategies for overcoming imatinib resistance in chronic myeloid leukemia.
P2860
Q37027402-141A2DF8-F7BE-444C-B443-F1F92CDBB663
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37027402-141A2DF8-F7BE-444C-B443-F1F92CDBB663
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2dd7f19c29daca80b29ab750210aba15342e7664
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.